Spontaneous Resolution of Intravitreal Steroid-Induced Bilateral Cytomegalovirus Retinitis

A 73-year-old woman underwent vitrectomy and intravitreal triamcinolone acetonide (IVTA) of the right eye and cataract surgery with IVTA of the left eye, for bilateral diabetic macular edema. The patient presented with visual loss in both eyes three-months postoperatively. The fundoscopic examination revealed white-yellow, necrotic peripheral lesions in the superotemporal quadrant of both eyes. Although bilateral acute retinal necrosis was suspected, azotemia resulting from diabetic nephropathy limited the use of acyclovir. Antiviral treatment was not started. A sample of the aqueous humor for polymerase chain reaction (PCR) analysis was obtained. One week later, the PCR results indicated the presence of cytomegalovirus (CMV). Since the retinal lesions did not progress and did not threaten the macula, the patient was followed without treatment for CMV. The retinal lesions progressively regressed and completely resolved in both eyes by six months of follow-up. Patients with IVTA-induced CMV retinitis may not require systemic treatment with ganciclovir.

[1]  T. Iida,et al.  Cytomegalovirus retinitis after intravitreal triamcinolone acetonide in an immunocompetent patient , 2008, Japanese Journal of Ophthalmology.

[2]  S. Byeon,et al.  Cytomegalovirus Retinitis After Intravitreous Triamcinolone Injection in a Patient with Central Retinal Vein Occlusion , 2008, Korean journal of ophthalmology : KJO.

[3]  Y. Rabinowitz.  Intacs for keratoconus. , 2010, Current opinion in ophthalmology.

[4]  M. Rougier,et al.  Cytomegalovirus retinitis following intravitreal injection of triamcinolone: report of two cases. , 2007, Acta ophthalmologica.

[5]  Rishi P. Singh,et al.  Cytomegalovirus retinitis after fluocinolone acetonide (Retisert) implant. , 2007, American journal of ophthalmology.

[6]  T. Margolis,et al.  Cytomegalovirus retinitis after intravitreous triamcinolone in an immunocompetent patient. , 2005, American journal of ophthalmology.

[7]  H. Doerr,et al.  The human eye (retina): a site of persistent HCMV infection? , 2005, Graefe's Archive for Clinical and Experimental Ophthalmology.

[8]  J. Mason,et al.  INTRAVITREAL CONCENTRATION AND CLEARANCE OF TRIAMCINOLONE ACETONIDE IN NONVITRECTOMIZED HUMAN EYES , 2004, Retina.

[9]  J. Ge,et al.  The relationship between human cytomegalovirus infection and atherosclerosis development , 2003, Molecular and Cellular Biochemistry.

[10]  Michael H. Miller,et al.  Intraocular concentration and pharmacokinetics of triamcinolone acetonide after a single intravitreal injection. , 2003, Ophthalmology.

[11]  Hugues Lortat-Jacob,et al.  Human cytomegalovirus binding to DC-SIGN is required for dendritic cell infection and target cell trans-infection. , 2002, Immunity.

[12]  M. Mets,et al.  Spontaneous resolution of cytomegalovirus retinitis in an infant with congenital cytomegalovirus infection. , 2001, Retina.

[13]  D. Skiest,et al.  Cytomegalovirus retinitis in the era of highly active antiretroviral therapy (HAART). , 1999, The American journal of the medical sciences.

[14]  N. Rao,et al.  Evaluation of the role of human retinal vascular endothelial cells in the pathogenesis of CMV retinitis. , 1999, Ocular immunology and inflammation.

[15]  D. Faulds,et al.  Ganciclovir. An update of its use in the prevention of cytomegalovirus infection and disease in transplant recipients. , 1998, Drugs.

[16]  M. Polis,et al.  Spontaneous and sustained resolution of CMV retinitis in patients receiving highly active antiretroviral therapy , 1998, The British journal of ophthalmology.

[17]  S. Stenglein,et al.  Human Cytomegalovirus Persistently Infects Aortic Endothelial Cells , 1998, Journal of Virology.

[18]  M. Polis,et al.  Therapeutic effect of combination antiretroviral therapy on cytomegalovirus retinitis. , 1997, JAMA.

[19]  J. Sinclair,et al.  Detection of endogenous human cytomegalovirus in CD34+ bone marrow progenitors. , 1996, The Journal of general virology.

[20]  J. Xu,et al.  Human cytomegalovirus latent gene expression in granulocyte-macrophage progenitors in culture and in seropositive individuals. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[21]  S. Stenglein,et al.  Cytomegalovirus persistence in macrophages and endothelial cells. , 1995, Scandinavian journal of infectious diseases. Supplementum.

[22]  M. Leon,et al.  Potential role of human cytomegalovirus and p53 interaction in coronary restenosis. , 1994, Science.

[23]  H. Volk,et al.  Cytomegalovirus reactivation and tumour necrosis factor , 1994, The Lancet.

[24]  D. Taylor,et al.  Detection of human cytomegalovirus in peripheral mononuclear cells and urine samples using PCR. , 1992, Molecular and cellular probes.

[25]  J. Sissons,et al.  Monocytes are a major site of persistence of human cytomegalovirus in peripheral blood mononuclear cells. , 1991, The Journal of general virology.

[26]  M. Walker,et al.  Polymerase chain reaction for detection of human cytomegalovirus infection in a blood donor population , 1991, British journal of haematology.

[27]  P. Minasi,et al.  In vivo reactivation of latent murine cytomegalovirus in the eye by immunosuppressive treatment. , 1990, Investigative ophthalmology & visual science.

[28]  H. L. Hennis,et al.  Cytomegalovirus retinitis. , 1989, Survey of ophthalmology.

[29]  C. Fletcher,et al.  Ganciclovir pharmacokinetics during renal impairment , 1988, Antimicrobial Agents and Chemotherapy.